Integrated Analysis of Patient Networks and Plasmid Genomes to Investigate a Regional, Multispecies Outbreak of Carbapenemase-Producing Enterobacterales Carrying Both bla IMP and mcr-9 Genes

Yu Wan, Ashleigh Myall, Adhiratha Boonyasiri, Frances Bolt, Alice Ledda, Siddharth Mookerjee, Andrea Y. Weiße, María Getino, Jane F. Turton, Hala Abbas, Rūta Prakapaitė, Akshay Sabnis, Alireza Abdolrasouli, Kenny Malpartida-Cardenas, Luca Miglietta, Hugo Donaldson, Mark Gilchrist, Katie L. Hopkins, Matthew J. Ellington, Jonathan A. Otter, Gerald Larrouy‐Maumus, Andrew M. Edwards, Jesús Rodríguez-Manzano, Xavier Didelot, Mauricio Barahona, Alison Holmes, Elita Jauneikaite, Frances DaviesThe Journal of Infectious Diseases 2024 · DOI

TL;DR

This study uses a novel approach combining patient movement data with whole-genome sequencing of bacteria to track a complex, multi-species outbreak of carbapenem-resistant Enterobacterales (CPE) in London hospitals. By integrating these datasets, researchers identified an interspecies, plasmid-mediated outbreak that was previously missed by standard investigations, highlighting the power of this combined approach for future outbreak detection and control.

What Problem Does This Paper Address?

Carbapenemase-producing Enterobacterales (CPE) are a major global health threat due to their resistance to last-resort antibiotics. Outbreaks of CPE are particularly challenging to control because these resistance genes can be carried on plasmids, which can easily transfer between different bacterial species. This makes it difficult to track the spread of resistance, especially when multiple species are involved in an outbreak within a complex healthcare setting like a hospital network. Traditional outbreak investigations often focus on single-species transmissions, potentially missing broader, interspecies spread mediated by mobile genetic elements like plasmids. This paper tackles the challenge of identifying and understanding such complex, multi-species outbreaks by integrating patient movement data with detailed genomic analysis of the causative pathogens.

Methods

The researchers employed a multi-pronged approach:

  • Patient Network Analysis: Electronic health records were used to reconstruct patient movement pathways and identify contacts between patients carrying IMP-encoding CPE. This involved defining a "contact" as two patients being on the same ward on the same day. A Walktrap community detection algorithm was used to cluster patients into groups with shared contacts, revealing potential transmission networks.
  • Whole-Genome Sequencing (WGS): DNA from 84 IMP-encoding CPE isolates was sequenced to identify the bacterial species and characterize the resistance genes and plasmids present.
  • Plasmid Phylogenomics: The genomes of the IncHI2 plasmids, which were found to carry the key resistance genes, were analyzed to reconstruct their evolutionary history and identify distinct lineages. This involved using tools like FastANI for genome assembly, MOB-suite for plasmid reconstruction, and IQ-Tree for phylogenetic analysis, with Gubbins and BactDating used to account for recombination and estimate divergence times.
  • Integrated Analysis: The patient contact networks were overlaid with plasmid phylogenomic data. This allowed researchers to correlate the genetic relatedness of plasmids with the spatiotemporal patterns of patient movements, inferring potential transmission routes and identifying key locations or pathways involved in the outbreak. A Kendall rank correlation coefficient was used to assess the relationship between plasmid phylogenetic distances and patient contact network distances.

Datasets

  • Electronic Health Records (EHRs): Data from a regional network of London hospitals (7 sites, 2000 inpatient beds) were used to reconstruct patient movement history (ward locations and time) for identified blaIMPCPE cases.
  • Bacterial Isolates: 84 IMP-encoding CPE isolates collected from screening or clinical samples between June 2016 and November 2019 from 116 patients.
  • Genomic Data: Illumina sequencing reads from the 84 CPE isolates were deposited in the European Nucleotide Archive (ENA) under BioProject PRJEB38818.
  • Reference Plasmid: IncHI2 plasmid pKA_P10 was used as a reference for plasmid sequence alignment.

Key Insights and Ideas

  • The Power of Integration: The study powerfully demonstrates that combining patient movement data with detailed genomic analysis of resistance-carrying plasmids is crucial for uncovering complex, interspecies outbreaks that would be missed by traditional methods.
  • Plasmid as the Driver: The IncHI2 plasmid emerged as the primary vehicle for the spread of both the carbapenemase gene (blaIMP) and the colistin resistance gene (mcr-9) across diverse bacterial species.
  • Hidden Transmission: A significant portion (59%) of the identified patient contacts involved different bacterial species, highlighting that standard outbreak definitions based on same-species transmission are insufficient for understanding the full scope of resistance spread.
  • Hospital 3 as a Hub: The analysis pinpointed Hospital 3, a specialist referral center, as a central hub for the outbreak, with a high burden of cases and bidirectional transfer pathways to other hospitals.
  • Silent Carriage: The high prevalence of blaIMPCPE carriage without clinical infection underscores the importance of screening and surveillance to prevent the silent spread of resistance.

Key Results

  • Multispecies Outbreak: The study identified an interspecies, plasmid-mediated outbreak of blaIMPCPE involving diverse Enterobacterales species (predominantly Klebsiella spp, Enterobacter spp, and Escherichia coli).
  • Plasmid Prevalence: 86% (72 of 84) of the isolates harbored an IncHI2 plasmid carrying both blaIMP and the colistin resistance gene mcr-9.
  • Plasmid Lineages: Phylogenetic analysis of the IncHI2 plasmids revealed 3 distinct lineages (A, B, and C), with lineage C being most prevalent in Hospital 3.
  • Network Correlation: A significant correlation was found between plasmid phylogenetic distances and patient contact network distances, suggesting that ward contacts mediated plasmid transmission.
  • Limited Clinical Infections: Despite the widespread carriage, only 4 clinical infections and no bloodstream infections were identified during the study period, emphasizing the role of asymptomatic carriage.

Limitations and Future Work

  • Long-Read Sequencing: The study acknowledges the limitation of not having long-read sequences, which could have provided complete plasmid sequences and potentially revealed more subtle similarities and differences.
  • Incomplete Pathway Data: Full pathway data was only available for identified positive cases, not all patients, which could have led to missed potential contacts or cases.
  • Limited Scope: Interactions in other hospital locations (e.g., imaging, endoscopy) and environmental sampling were not examined, which could provide further insights into transmission.
  • Future Work: The authors suggest that their integrated approach provides a framework for real-time identification of pathogen spread and can be generalized to a wide range of scenarios. They also highlight the need for plasmid analysis across different resistance mechanisms and species as a standard for future investigations. The findings reinforce the importance of screening for silent carriage and cautious antimicrobial stewardship.

Summary updated

Abstract

Combined, our patient network and plasmid analyses demonstrate an interspecies, plasmid-mediated outbreak of blaIMPCPE, which remained unidentified during standard investigations. With DNA sequencing and multimodal data incorporation, the outbreak investigation approach proposed here provides a framework for real-time identification of key factors causing pathogen spread. Plasmid-level outbreak analysis reveals that resistance spread may be wider than suspected, allowing more interventions to stop transmission within hospital networks.SummaryThis was an investigation, using integrated pathway networks and genomics methods, of the emergence of imipenemase-encoding carbapenemase-producing Enterobacterales among diverse Enterobacterales species between 2016 and 2019 in patients across a London regional hospital network, which was missed on routine investigations.
BibTeX
@article{wan2024integrated,
  author = {Yu Wan and Ashleigh Myall and Adhiratha Boonyasiri and Frances Bolt and Alice Ledda and Siddharth Mookerjee and Andrea Y. Weiße and María Getino and Jane F. Turton and Hala Abbas and Rūta Prakapaitė and Akshay Sabnis and Alireza Abdolrasouli and Kenny Malpartida-Cardenas and Luca Miglietta and Hugo Donaldson and Mark Gilchrist and Katie L. Hopkins and Matthew J. Ellington and Jonathan A. Otter and Gerald Larrouy‐Maumus and Andrew M. Edwards and Jesús Rodríguez-Manzano and Xavier Didelot and Mauricio Barahona and Alison Holmes and Elita Jauneikaite and Frances Davies},
  title = {{Integrated Analysis of Patient Networks and Plasmid Genomes to Investigate a Regional, Multispecies Outbreak of Carbapenemase-Producing Enterobacterales Carrying Both <i>bla</i> IMP and <i>mcr-9</i> Genes}},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae019},
}
Figure